Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04313712 · ClinicalTrials.gov registry record
Pre-post Evaluation of the Safety and Efficacy of Ibogaine-Magnesium Therapy in Veterans With Repeated Blast Exposure
A clinical trial of Head Injury Trauma and Blast or Combat Exposure, sponsored by Stanford University.
- Active
- Registry status
- 30
- Enrollment target
- 1
- Study location
NCT04313712 is a study of Head Injury Trauma and Blast or Combat Exposure that is active but no longer recruiting, run by Stanford University. The registered enrollment target is 30 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04313712, a study of Head Injury Trauma and Blast or Combat Exposure, is active but no longer recruiting, sponsored by Stanford University.
- ACTIVE NOT RECRUITING
- Registry status
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
A Pre-post Study Evaluating the Safety and Efficacy of Ibogaine-Magnesium Therapy in Veterans with Sequelae of Repeated Blast Exposure.
Conditions Studied
Interventions
- DRUG ibogaine with magnesium treatment
Study Locations (1)
California
- Stanford University School of Medicine - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2021-11-15 |
| Est. Completion | 2025-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04313712
The ClinicalTrials.gov registry entry for NCT04313712 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Head Injury Trauma appearing as the primary indexed condition, and to 1 intervention - of which ibogaine with magnesium treatment is the first listed.
NCT04313712 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04313712 about?
NCT04313712 is a clinical study titled "Pre-post Evaluation of the Safety and Efficacy of Ibogaine-Magnesium Therapy in Veterans With Repeated Blast Exposure". A Pre-post Study Evaluating the Safety and Efficacy of Ibogaine-Magnesium Therapy in Veterans with Sequelae of Repeated Blast Exposure.
What is the current status of trial NCT04313712?
This trial is currently active not recruiting. The enrollment target is 30 participants. The study started on 2021-11-15. Estimated completion is 2025-02.
What conditions does trial NCT04313712 study?
This clinical trial studies the following conditions: Head Injury Trauma, Blast or Combat Exposure.
What interventions are being tested in trial NCT04313712?
The interventions under investigation include: ibogaine with magnesium treatment (DRUG).
Who is sponsoring clinical trial NCT04313712?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04313712 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Head Injury Trauma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.